REDHIRA Trademark

Trademark Overview

On Monday, October 27, 2014, a trademark application was filed for REDHIRA with the United States Patent and Trademark Office. The USPTO has given the REDHIRA trademark a serial number of 86435799. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 28, 2018. This trademark is owned by AstraZeneca AB. The REDHIRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
redhira

General Information

Serial Number86435799
Word MarkREDHIRA
Filing DateMonday, October 27, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 28, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 1, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 5, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Tuesday, May 29, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 28, 2018ABANDONMENT - NO USE STATEMENT FILED
Friday, October 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 18, 2017EXTENSION 4 GRANTED
Wednesday, October 18, 2017EXTENSION 4 FILED
Wednesday, October 18, 2017TEAS EXTENSION RECEIVED
Friday, April 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 4, 2017EXTENSION 3 GRANTED
Tuesday, April 4, 2017EXTENSION 3 FILED
Tuesday, April 4, 2017TEAS EXTENSION RECEIVED
Thursday, October 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 26, 2016EXTENSION 2 GRANTED
Wednesday, October 5, 2016EXTENSION 2 FILED
Wednesday, October 26, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 5, 2016TEAS EXTENSION RECEIVED
Saturday, April 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 14, 2016EXTENSION 1 GRANTED
Thursday, April 14, 2016EXTENSION 1 FILED
Thursday, April 14, 2016TEAS EXTENSION RECEIVED
Tuesday, October 27, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 1, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 1, 2015PUBLISHED FOR OPPOSITION
Wednesday, August 12, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 28, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 20, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 14, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 14, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 8, 2015ASSIGNED TO LIE
Monday, June 29, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 19, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 19, 2015NON-FINAL ACTION E-MAILED
Thursday, February 19, 2015NON-FINAL ACTION WRITTEN
Saturday, February 14, 2015ASSIGNED TO EXAMINER
Wednesday, November 5, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 30, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

redhira diseases disorders pharmaceutical preparations nervous system inflammation gastrointestinal infection metabolic